News
![Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer
Waters Corporation (NYSE:WAT) today introduced the new Xevo™ TQ Absolute system, the most sensitive and compact benchtop tandem mass spec in its class.i
This press release features multimedia
![Waters präsentiert eine schnellere, zuverlässigere und automatisierte Lösung für die Massen- und Reinheitsanalyse von Biomolekülen](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Waters präsentiert eine schnellere, zuverlässigere und automatisierte Lösung für die Massen- und Reinheitsanalyse von Biomolekülen
Die Waters Corporation (NYSE:WAT) stellte heute neue Software und analytische Säulen zur Unterstützung der Erforschung und Entwicklung von Biomolekülen vor. Mit der neuen App 'Intact Mass' von
![Waters Introduces Faster, Reliable and Automated Solution for Mass and Purity Analysis of Biomolecules](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Waters Introduces Faster, Reliable and Automated Solution for Mass and Purity Analysis of Biomolecules
Waters Corporation (NYSE:WAT) today introduced new software and analytical columns to aid biomolecule drug discovery and development. The new Waters™ Intact Mass app on waters_connect™ allows
![Dexcom G7 erhält CE-Kennzeichnung – Das kontinuierliche Blutzuckermesssystem der nächsten Generation wird das Diabetesmanagement revolutionieren](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Dexcom G7 erhält CE-Kennzeichnung – Das kontinuierliche Blutzuckermesssystem der nächsten Generation wird das Diabetesmanagement revolutionieren
DexCom, Inc. (NASDAQ:DXCM), der weltweit führende Anbieter im Bereich der kontinuierlichen Blutzuckermessung in Echtzeit für Menschen mit Diabetes, gab heute bekannt, dass das Unternehmen die
![Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark (Conformité Européenne) for the Dexcom G7
![Alacer Corp. Launches New Eco-Conscious Toothpaste Brand Natean®](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Alacer Corp. Launches New Eco-Conscious Toothpaste Brand Natean®
Alacer Corp. today announced the launch of Natean®, a new eco-conscious oral healthcare brand providing products to consumers looking for nature-inspired toothpastes that deliver essential oral
![Ontario Announces Public Coverage for the Dexcom G6 Continuous Glucose Monitoring System under the Assistive Devices Program](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Ontario Announces Public Coverage for the Dexcom G6 Continuous Glucose Monitoring System under the Assistive Devices Program
Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM), is pleased to announce that effective March 14 2022, the Ontario government will provide coverage
![Humana Launches CenterWell Home Health](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Humana Launches CenterWell Home Health
One year after launching the CenterWell brand to represent Humana’s payer-agnostic healthcare service offerings, Humana Inc. (NYSE: HUM) has started to transition Kindred at Home’s home health
![Humana Earns Top Score in Human Rights Campaign Foundation’s 2022 Corporate Equality Index](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Humana Earns Top Score in Human Rights Campaign Foundation’s 2022 Corporate Equality Index
Leading health insurer and health care services company Humana Inc. (NYSE: HUM), proudly announced that it received a score of 100 on the Human Rights Campaign Foundation’s 2022 Corporate Equality
![Dexcom G6 Continuous Glucose Monitoring System Now Covered in Alberta for Children and Youth Living With Diabetes](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Dexcom G6 Continuous Glucose Monitoring System Now Covered in Alberta for Children and Youth Living With Diabetes
Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM), announced today that people with diabetes who are under 18 years old and require ongoing use of
![Waters Earns Top Score in Human Rights Campaign Foundation’s 2022 Corporate Equality Index](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Waters Earns Top Score in Human Rights Campaign Foundation’s 2022 Corporate Equality Index
Waters Corporation (NYSE:WAT) announced that it received a score of 100 on the Human Rights Campaign Foundation’s 2022 Corporate Equality Index (CEI), the nation’s foremost benchmarking survey and
![Humana Foundation Names Tiffany Benjamin As Chief Executive Officer](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Humana Foundation Names Tiffany Benjamin As Chief Executive Officer
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) has announced the appointment of Tiffany Benjamin as its new Foundation CEO, effective January 3, 2022.
This press release
![Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab
Agilent Technologies Inc. (NYSE: A) has announced that the Agilent Cary 3500 UV-Vis Spectrophotometer is now compatible with the Agilent OpenLab software suite of products. The Cary 3500 UV-Vis
![Astra Zeneca: Wirbel um COVID-19-Impfstoff](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Astra Zeneca: Wirbel um COVID-19-Impfstoff
AstraZeneca (WKN: 886455) teilte am Montag mit, dass die Nebenwirkungen seines potenziellen Corona-Impfstoffs bei älteren Menschen geringer seien. Die Wirkstoff-Hoffnung des britischen Pharmariesen
![AstraZeneca: Patient erkrankt – Impfstoff-Studie gestoppt!](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
AstraZeneca: Patient erkrankt – Impfstoff-Studie gestoppt!
Rückschlag beim Corona-Impfstoff: Die britische Pharmaschmiede AstraZeneca (WKN: 886455) stoppt vorsorglich die entscheidende Studienphase. Ein Teilnehmer der UK-Studie habe Nebenwirkungen verspürt
![Intuitive Surgical: Absolut überzeugend!](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Intuitive Surgical: Absolut überzeugend!
In den USA hat die Berichtssaison bereits begonnen, so dass derzeit ein Unternehmen nach dem anderen seine aktuellen Quartalszahlen vorlegt. Gestern Abend, nachbörslich, war nun der
![Bayer: Monsanto-Turbulenzen wohl bald vergessen!](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Bayer: Monsanto-Turbulenzen wohl bald vergessen!
Angetrieben von der Hoffnung auf einen außergerichtlichen Vergleich sprang die Bayer-Aktie (WKN: BAY001) am Montag von 57,65 auf 62,13 Euro um +7,77%. Die dunklen Wolken über dem Pharma- und
![Gilead Sciences: Wer wird nun der nächste Corona-Gewinner?](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Gilead Sciences: Wer wird nun der nächste Corona-Gewinner?
Auf dem US-Konzern Gilead Sciences (WKN: 885823) und dem Wirkstoff Remdesivir liegen die Hoffnungen vieler Anleger. Doch Medikamente und Impstoffe sind nicht die einzigen Corona-Profiteure.
![Pfizer Highlights Diverse Oncology Portfolio and Combination Approaches at ESMO 2024http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Pfizer Highlights Diverse Oncology Portfolio and Combination Approaches at ESMO 2024
Pfizer Inc. (NYSE: PFE) continues to showcase potential practice-changing research and next-generation candidates across its robust Oncology portfolio at the European Society for Medical Oncology
![Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzhqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dc80e0ef4017de010dd6eedba979079258398fba/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Dexcom_Registered_no_bug.jpg?locale=us)
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being
![Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision MedicinePhoto, wide shot, wide-angle lens, soft focus, Auto parts supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-XjwbnkgTrFCFx6Y3gLbqZBCj.png?st=2023-05-13T09%3A21%3A52Z&se=2023-05-13T11%3A21%3A52Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-13T06%3A55%3A39Z&ske=2023-05-14T06%3A55%3A39Z&sks=b&skv=2021-08-06&sig=wJlbn/o%2BieTjclaQNRsJc%2BDDZieC0UCS6BPi5tapxAA%3D](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMzhMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d359ac63ba0355c4ac2a70d0d5c50a4d51e8ef7d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/o-2BieTjclaQNRsJc-2BDDZieC0UCS6BPi5tapxAA-3D.png?locale=us)
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
Agilent Technologies Inc., (NYSE: A) today announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, following receipt of California State clinical laboratory
![Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzhqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dc80e0ef4017de010dd6eedba979079258398fba/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Dexcom_Registered_no_bug.jpg?locale=us)
Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will spotlight the significant benefits of its innovative CGM technology at
![Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
![Humana and Evergreen Nephrology Introduce New Specialized Care Program for Patients Living with Kidney Disease: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBaXNCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--3d3c39355769d1759c5221ae0bf511106538ecb5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Humana_logo.png?locale=us)
Humana and Evergreen Nephrology Introduce New Specialized Care Program for Patients Living with Kidney Disease
Humana Inc. (NYSE: HUM), a leading health and well-being company, announced a new value-based kidney care program with Evergreen Nephrology designed to advance quality of care and help optimize
![CenterWell Home Health Launches 20th Food Fundraising Drive: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBaXNCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--3d3c39355769d1759c5221ae0bf511106538ecb5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Humana_logo.png?locale=us)
CenterWell Home Health Launches 20th Food Fundraising Drive
CenterWell Home Health, one of America’s largest home health providers, has launched its 20th annual Food Fundraising Drive, an effort to fight food insecurity in the communities it serves.